)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Kirin Holdings Company
Kirin Holdings Company (2503) investor relations material
Kirin Holdings Company Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary7 Aug, 2026
Executive summary
Revenue for Q2 FY2026 rose 7.2% year-over-year to ¥1,217.9 billion, with normalized operating profit up 36.1% to ¥128.3 billion and profit attributable to owners up 92.5% to ¥101.7 billion; basic EPS nearly doubled to ¥126.33.
Upward revision of full-year FY2026 forecasts: NOP raised to ¥253.0 billion, profit attributable to owners to ¥160.0 billion, and EPS to ¥200.
Comprehensive income surged to ¥157,581 million from ¥2,282 million a year earlier.
Gains from the sale of Four Roses and lower R&D expenses from discontinuation of rocatinlimab development contributed to profit growth.
Major gain from the sale of Four Roses Distillery, LLC completed in April 2026.
Financial highlights
Gross profit rose 11.3% to ¥592.7 billion; normalized OP margin (excl. liquor tax) improved to 11.7%.
Operating profit nearly doubled to ¥129,042 million from ¥68,723 million.
Cash flows from operating activities increased by ¥70.1 billion to ¥137.3 billion; free cash flow reached ¥191.0 billion.
Cash and cash equivalents at period end increased to ¥168,075 million from ¥132,408 million.
Gross D/E ratio improved to 0.62 from 0.91 year-over-year.
Outlook and guidance
FY2026 revenue forecast revised to ¥2,480.0 billion (+1.9% YoY); NOP to ¥253.0 billion (+0.5% YoY); profit attributable to owners to ¥160.0 billion (+8.4% YoY); basic EPS projected at ¥200.
Annual dividend forecast raised to ¥76 per share.
ROIC target maintained at 7.7%.
Middle East situation expected to impact profits by ~¥10 billion in FY2026; cost controls and price revisions planned to mitigate.
Profit before tax forecasted at ¥259,000 million (+8.9% YoY).
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Kirin Holdings Company
- Q1 FY2026 saw robust profit growth and margin improvement across all major segments.2503
Q1 2026 - Targets high single-digit EPS growth, ROIC ≥10%, and 3 trillion yen market cap by 2035.2503Investor presentation
- Profit more than doubled, Health Science turned profitable, and major portfolio moves were made.2503Q4 2025
- Profit and revenue up, FANCL fully consolidated, Health Science segment surges.2503Q3 2025
- Revenue rose 3.7% YoY, but profit and EPS fell on restructuring and FX impacts.2503Q2 2025
- H1 2024 saw robust revenue and profit growth, but full-year profit guidance was lowered.2503Q2 2024
- Revenue and operating profit rose, but net profit dropped on FANCL acquisition loss.2503Q3 2024
- Revenue and profit grew, but net income fell on FX and equity changes from FANCL buyout.2503Q1 2025
- FY2025 profit is set to rebound sharply, driven by Health Science and Alcoholic Beverages.2503Q4 2024
Next Kirin Holdings Company earnings date
Q3 202611 Nov, 2026
Kirin Holdings Company
Next Kirin Holdings Company earnings date
Q3 202611 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Kirin Holdings Company is a Japanese conglomerate primarily engaged in the production and distribution of beverages, pharmaceuticals, and health science products. Its beverage portfolio includes beer, wine, soft drinks, and other alcoholic beverages, while its health science and pharmaceutical divisions focus on wellness products and medical solutions. Kirin operates internationally, serving markets in Asia, Oceania, and beyond. The company combines traditional brewing expertise with biotechnology research to expand into health-focused products and functional beverages. The company is headquartered in Tokyo, Japan, and its shares are listed on the Tokyo Stock Exchange.